Functional analysis of microRNA-122 binding sequences of hepatitis C virus and identification of variants with high resistance against a specific antagomir

Journal of General Virology

Volumn 97, Issue 6, 2016, Pages 1381-1394

  Li, Yi Ping ^a,b,c   van Pham, Long ^b   Uzcategui, Nathalie ^a,b   Bukh, Jens ^a,b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 122; MIRAVIRSEN; SMALL NUCLEOLAR RNA; 5' UNTRANSLATED REGION; ANTAGOMIR; MICRORNA; MIRN122 MICRORNA, HUMAN; VIRUS RNA;

5' UNTRANSLATED REGION; AMPLICON; ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 2; HEPATITIS C VIRUS GENOTYPE 3; HEPATITIS C VIRUS GENOTYPE 4; HEPATITIS C VIRUS GENOTYPE 5; HEPATITIS C VIRUS GENOTYPE 6; HUMAN; HUMAN CELL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; REVERSE GENETICS; RNA BINDING; RNA SEQUENCE; SEQUENCE ANALYSIS; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS RESISTANCE; GENETICS; HEPACIVIRUS; METABOLISM; MUTATION; PHYSIOLOGY;

5' UNTRANSLATED REGIONS; ANTAGOMIRS; DRUG RESISTANCE, VIRAL; HEPACIVIRUS; MICRORNAS; MUTATION; REVERSE GENETICS; RNA, VIRAL; VIRUS REPLICATION;

EID: 84976514525     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000445     Document Type: Article

References (38)

1. Alter, H. J. & Seeff, L. B. (2000). Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 20, 17-35.
2. Bukh, J. (2012). Animal models for the study of hepatitis C virus infection and related liver disease. Gastroenterology 142, 1279-1287.
3. Bukh, J. & Purcell, R. H. (2006). A milestone for hepatitis C virus research: a virus generated in cell culture is fully viable in vivo. Proc Natl Acad Sci U S A 103, 3500-3501.
4. Bukh, J., Miller, R. H., Kew, M. C. & Purcell, R. H. (1993). Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma. Proc Natl Acad Sci U S A 90, 1848-1851.
5. Chang, J., Nicolas, E., Marks, D., Sander, C., Lerro, A., Buendia, M. A., Xu, C., Mason, W. S., Moloshok, T. & Taylor, J. M. (2004). miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 1, 106-113.
6. Elmén, J., Lindow, M., Silahtaroglu, A., Bak, M., Christensen, M., Lind- Thomsen, A., Hedtjärn, M., Hansen, J. B., Hansen, H. F. & Kauppinen, S. (2008). Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 36, 1153-1162.
7. Farci, P., Bukh, J. & Purcell, R. H. (1997). The quasispecies of hepatitis C virus and the host immune response. Springer Semin Immunopathol 19, 5-26.
8. Forns, X., Purcell, R. H. & Bukh, J. (1999). Quasispecies in viral persistence and pathogenesis of hepatitis C virus. Trends Microbiol 7, 402-410.
9. Friebe, P., Lohmann, V., Krieger, N. & Bartenschlager, R. (2001). Sequences in the 5’ nontranslated region of hepatitis C virus required for RNA replication. J Virol 75, 12047-12057.
10. Gottwein, J. M. & Bukh, J. (2008). Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems. Adv Virus Res 71, 51-133.
11. Gottwein, J. M., Scheel, T. K., Hoegh, A. M., Lademann, J. B., Eugen- Olsen, J., Lisby, G. & Bukh, J. (2007). Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses. Gastroenterology 133, 1614-1626.
12. Gottwein, J. M., Scheel, T. K., Callendret, B., Li, Y. P., Eccleston, H. B., Engle, R. E., Govindarajan, S., Satterfield, W., Purcell, R. H. & Bukh, J. (2010). Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies. J Virol 84, 5277-5293.
13. Henke, J. I., Goergen, D., Zheng, J., Song, Y., Schüttler, C. G., Fehr, C., Jünemann, C. & Niepmann, M. (2008). microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 27, 3300-3310.
14. Honda, M., Beard, M. R., Ping, L. H. & Lemon, S. M. (1999). A phylogenetically conserved stem-loop structure at the 5’ border of the internal ribosome entry site of hepatitis C virus is required for capindependent viral translation. J Virol 73, 1165-1174.
15. Hrdlickova, B., de Almeida, R. C., Borek, Z. & Withoff, S. (2014). Genetic variation in the non-coding genome: Involvement of micro- RNAs and long non-coding RNAs in disease. Biochim Biophys Acta 1842, 1910-1922.
16. Israelow, B., Mullokandov, G., Agudo, J., Sourisseau, M., Bashir, A., Maldonado, A. Y., Dar, A. C., Brown, B. D. & Evans, M. J. (2014). Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors. Nat Commun 5, 5408.
17. Jangra, R. K., Yi, M. & Lemon, S. M. (2010). Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. J Virol 84, 6615-6625.
18. Janssen, H. L., Reesink, H. W., Lawitz, E. J., Zeuzem, S., Rodriguez- Torres, M., Patel, K., van der Meer, A. J., Patick, A. K., Chen, A. & Hodges, M. R. (2013). Treatment of HCV infection by targeting microRNA. N Engl J Med 368, 1685-1694.
19. Jopling, C. L. (2008). Regulation of hepatitis C virus by microRNA- 122. Biochem Soc Trans 36, 1220-1223.
20. Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M. & Sarnow, P. (2005). Modulation of hepatitis C virus RNA abundance by a liverspecific MicroRNA. Science 309, 1577-1581.
21. Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., Lindow, M., Munk, M. E., Kauppinen, S. & Ørum, H. (2010). Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198-201.
22. Li, Y. P., Gottwein, J. M., Scheel, T. K., Jensen, T. B. & Bukh, J. (2011a). MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5′ UTR. Proc Natl Acad Sci U S A 108, 4991-4996.
23. Li, Y. P., Ramirez, S., Gottwein, J. M. & Bukh, J. (2011b). Non-genotype- specific role of the hepatitis C virus 5′ untranslated region in virus production and in inhibition by interferon. Virology 421, 222-234.
24. Li, Y. P., Ramirez, S., Gottwein, J. M., Scheel, T. K., Mikkelsen, L., Purcell, R. H. & Bukh, J. (2012a). Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains. Proc Natl Acad Sci U S A 109, E1101-E1110.
25. Li, Y. P., Ramirez, S., Jensen, S. B., Purcell, R. H., Gottwein, J. M. & Bukh, J. (2012b). Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system. Proc Natl Acad Sci U S A 109, 19757-19762.
26. Li, Y., Masaki, T., Yamane, D., McGivern, D. R. & Lemon, S. M. (2013). Competing and noncompeting activities of miR-122 and the 5’ exonuclease Xrn1 in regulation of hepatitis C virus replication. Proc Natl Acad Sci U S A 110, 1881-1886.
27. Li, Y. P., Ramirez, S., Humes, D., Jensen, S. B., Gottwein, J. M. & Bukh, J. (2014). Differential sensitivity of 5’UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors. Gastroenterology 146, 812-821.
28. Lindenbach, B. D., Evans, M. J., Syder, A. J., Wölk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R. & Rice, C. M. (2005). Complete replication of hepatitis C virus in cell culture. Science 309, 623-626.
29. Luna, J. M., Scheel, T. K., Danino, T., Shaw, K. S., Mele, A., Fak, J. J., Nishiuchi, E., Takacs, C. N., Catanese, M. T. & Darnell, R. B. (2015). Hepatitis C virus RNA functionally sequesters miR-122. Cell 160, 1099-1110.
30. Luo, G., Xin, S. & Cai, Z. (2003). Role of the 5’-proximal stem-loop structure of the 5’ untranslated region in replication and translation of hepatitis C virus RNA. J Virol 77, 3312-3318.
31. Machlin, E. S., Sarnow, P. & Sagan, S. M. (2011). Masking the 5’ terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex. Proc Natl Acad Sci U S A 108, 3193-3198.
32. Moradpour, D., Penin, F. & Rice, C. M. (2007). Replication of hepatitis C virus. Nat Rev Microbiol 5, 453-463.
33. Ottosen, S., Parsley, T. B., Yang, L., Zeh, K., van Doorn, L. J., van der Veer, E., Raney, A. K., Hodges, M. R. & Patick, A. K. (2015). In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122. Antimicrob Agents Chemother 59, 599-608.
34. Pietschmann, T., Kaul, A., Koutsoudakis, G., Shavinskaya, A., Kallis, S., Steinmann, E., Abid, K., Negro, F., Dreux, M. & Bartenschlager, R. (2006). Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci U S A 103, 7408-7413.
35. Scheel, T. K., Gottwein, J. M., Carlsen, T. H., Li, Y. P., Jensen, T. B., Spengler, U., Weis, N. & Bukh, J. (2011). Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations. J Virol 85, 2891-2906.
36. Shimakami, T., Yamane, D., Jangra, R. K., Kempf, B. J., Spaniel, C., Barton, D. J. & Lemon, S. M. (2012). Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci U S A 109, 941-946.
37. Smith, D. B., Bukh, J., Kuiken, C., Muerhoff, A. S., Rice, C. M., Stapleton, J. T. & Simmonds, P. (2014). Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology (Baltimore, Md.) 59, 318-327.
38. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H. G. & Liang, T. J. (2005). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11, 791-796.